Royal Bank Of Canada Foghorn Therapeutics Inc. Transaction History

Royal Bank Of Canada

  • $579 Billion
  • Q3 2025

A detailed history of Royal Bank Of Canada transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 1,736 shares of FHTX stock, worth $8,141. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,736
Previous 1,064 63.16%
Holding current value
$8,141
Previous $5,000 60.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$4.58 - $6.5 $3,077 - $4,368
672 Added 63.16%
1,736 $8,000
Q2 2025

Nov 21, 2025
BUY
$3.15 - $4.9 $3,244 - $5,047
1,030 Added 3029.41%
1,064 $5,000
Q2 2025

Aug 14, 2025
BUY
$3.15 - $4.9 $3,244 - $5,047
1,030 Added 3029.41%
1,064 $5,000
Q1 2025

Nov 21, 2025
SELL
$3.52 - $6.16 $5,991 - $10,484
-1,702 Reduced 98.04%
34 $0
Q1 2025

May 15, 2025
SELL
$3.52 - $6.16 $8,993 - $15,738
-2,555 Reduced 98.69%
34 $0
Q4 2024

Feb 14, 2025
SELL
$4.61 - $9.35 $1,166 - $2,365
-253 Reduced 8.9%
2,589 $12,000
Q3 2024

Nov 14, 2024
SELL
$4.8 - $9.99 $31,363 - $65,274
-6,534 Reduced 69.69%
2,842 $26,000
Q2 2024

Aug 14, 2024
BUY
$5.05 - $8.0 $4,686 - $7,424
928 Added 10.98%
9,376 $53,000
Q1 2024

Nov 05, 2024
SELL
$2.82 - $7.94 $2,616 - $7,368
-928 Reduced 9.9%
8,448 $56,000
Q1 2024

May 15, 2024
BUY
$2.82 - $7.94 $5,490 - $15,459
1,947 Added 29.95%
8,448 $56,000
Q4 2023

Feb 14, 2024
BUY
$2.94 - $6.76 $902 - $2,075
307 Added 4.96%
6,501 $41,000
Q3 2023

Nov 14, 2023
SELL
$5.0 - $9.87 $6,360 - $12,554
-1,272 Reduced 17.04%
6,194 $30,000
Q2 2023

Aug 14, 2023
SELL
$5.37 - $8.84 $182 - $300
-34 Reduced 0.45%
7,466 $52,000
Q1 2023

May 15, 2023
BUY
$4.66 - $8.99 $5,130 - $9,897
1,101 Added 17.21%
7,500 $46,000
Q4 2022

Feb 14, 2023
BUY
$5.44 - $9.46 $16,069 - $27,944
2,954 Added 85.75%
6,399 $40,000
Q3 2022

Nov 14, 2022
BUY
$7.52 - $18.01 $992 - $2,377
132 Added 3.98%
3,445 $29,000
Q2 2022

Aug 15, 2022
SELL
$8.48 - $16.84 $9,234 - $18,338
-1,089 Reduced 24.74%
3,313 $46,000
Q1 2022

May 16, 2022
SELL
$8.87 - $22.1 $24,090 - $60,023
-2,716 Reduced 38.16%
4,402 $67,000
Q4 2021

Feb 14, 2022
BUY
$10.79 - $22.87 $16,951 - $35,928
1,571 Added 28.32%
7,118 $162,000
Q3 2021

Nov 15, 2021
BUY
$8.33 - $15.02 $24,648 - $44,444
2,959 Added 114.34%
5,547 $78,000
Q2 2021

Aug 16, 2021
BUY
$9.32 - $13.26 $24,120 - $34,316
2,588 New
2,588 $27,000

Others Institutions Holding FHTX

# of Institutions
88
Shares Held
37M
Call Options Held
100
Put Options Held
0
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $195M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email